• 1
    Quarto M, Germinario C, Fontana A, Barbuti S. HIV transmission through kidney transplantation from a living related donor. N Engl J Med 1989; 320: 1754.
  • 2
    Fischer SA, Avery RK. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant 2009; 9 Suppl 4: S7S18.
  • 3
    CDC. Guidelines for preventing transmission of human immuno-defi ciency virus through transplantation of human tissue and organs. MMWR 1994; 43(No. RR-8).
  • 4
    Fiebig EW, Wright DJ, Rawal BD et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17: 18711879.
  • 5
    Keele B F, Giorgi EE, Salazar-Gonzalez JF et al. Identifi cation and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 2008; 105: 75527557.
  • 6
    Kucirka LM, Alexander C, Namuyinga R, Hanrahan C, Montgomery RA, Segev DL. Viral nucleic acid testing (NAT) and OPO-level disposition of high-risk donor organs. Am J Transplant 2009; 9: 620628.
  • 7
    Ellingson K, Seem D, Nowicki M et al. Estimated risk of human mmunodefi ciency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States. Am J Transplant 2011; 11: 12011208.
  • 8
    Kucirka LM, Sarathy H, Govindan P et al. Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis. Am J Transplant 2011; March 2 [Epub ahead of print]